-
Je něco špatně v tomto záznamu ?
Roles of Macrophage Polarization and Macrophage-Derived miRNAs in Pulmonary Fibrosis
A. Kishore, M. Petrek
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
NLK
Directory of Open Access Journals
od 2010
Free Medical Journals
od 2010
PubMed Central
od 2010
Europe PubMed Central
od 2010
Open Access Digital Library
od 2010-01-01
Open Access Digital Library
od 2010-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2010
- MeSH
- aktivace makrofágů genetika imunologie MeSH
- biologické markery MeSH
- biologické modely MeSH
- cytokiny metabolismus MeSH
- exozómy metabolismus MeSH
- lidé MeSH
- makrofágy imunologie metabolismus MeSH
- mediátory zánětu metabolismus MeSH
- mikro RNA genetika MeSH
- náchylnost k nemoci * MeSH
- plasticita buňky MeSH
- plicní fibróza etiologie metabolismus patologie MeSH
- regulace genové exprese MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
This mini-review summarizes the current evidence for the role of macrophage activation and polarization in inflammation and immune response pertinent to interstitial lung disease, specifically pulmonary fibrosis. In the fibrosing lung, the production and function of inflammatory and fibrogenic mediators involved in the disease development have been reported to be regulated by the effects of polarized M1/M2 macrophage populations. The M1 and M2 macrophage phenotypes were suggested to correspond with the pro-inflammatory and pro-fibrogenic signatures, respectively. These responses towards tissue injury followed by the development and progression of lung fibrosis are further regulated by macrophage-derived microRNAs (miRNAs). Besides cellular miRNAs, extracellular exosomal-miRNAs derived from M2 macrophages have also been proposed to promote the progression of pulmonary fibrosis. In a future perspective, harnessing the noncoding miRNAs with a key role in the macrophage polarization is, therefore, suggested as a promising therapeutic strategy for this debilitating disease.
Accuscript Consultancy Ludhiana India
Departments of Experimental Medicine and Immunology University Hospital Olomouc Olomouc Czechia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22003928
- 003
- CZ-PrNML
- 005
- 20220127145720.0
- 007
- ta
- 008
- 220113s2021 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fimmu.2021.678457 $2 doi
- 035 __
- $a (PubMed)34489932
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Kishore, Amit $u Department of Pathological Physiology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czechia $u Accuscript Consultancy, Ludhiana, India
- 245 10
- $a Roles of Macrophage Polarization and Macrophage-Derived miRNAs in Pulmonary Fibrosis / $c A. Kishore, M. Petrek
- 520 9_
- $a This mini-review summarizes the current evidence for the role of macrophage activation and polarization in inflammation and immune response pertinent to interstitial lung disease, specifically pulmonary fibrosis. In the fibrosing lung, the production and function of inflammatory and fibrogenic mediators involved in the disease development have been reported to be regulated by the effects of polarized M1/M2 macrophage populations. The M1 and M2 macrophage phenotypes were suggested to correspond with the pro-inflammatory and pro-fibrogenic signatures, respectively. These responses towards tissue injury followed by the development and progression of lung fibrosis are further regulated by macrophage-derived microRNAs (miRNAs). Besides cellular miRNAs, extracellular exosomal-miRNAs derived from M2 macrophages have also been proposed to promote the progression of pulmonary fibrosis. In a future perspective, harnessing the noncoding miRNAs with a key role in the macrophage polarization is, therefore, suggested as a promising therapeutic strategy for this debilitating disease.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a biologické markery $7 D015415
- 650 _2
- $a plasticita buňky $7 D000066670
- 650 _2
- $a cytokiny $x metabolismus $7 D016207
- 650 12
- $a náchylnost k nemoci $7 D004198
- 650 _2
- $a exozómy $x metabolismus $7 D055354
- 650 _2
- $a regulace genové exprese $7 D005786
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mediátory zánětu $x metabolismus $7 D018836
- 650 _2
- $a aktivace makrofágů $x genetika $x imunologie $7 D008262
- 650 _2
- $a makrofágy $x imunologie $x metabolismus $7 D008264
- 650 _2
- $a mikro RNA $x genetika $7 D035683
- 650 _2
- $a biologické modely $7 D008954
- 650 _2
- $a plicní fibróza $x etiologie $x metabolismus $x patologie $7 D011658
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Petrek, Martin $u Department of Pathological Physiology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czechia $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czechia $u Departments of Experimental Medicine, and Immunology, University Hospital Olomouc, Olomouc, Czechia
- 773 0_
- $w MED00181405 $t Frontiers in immunology $x 1664-3224 $g Roč. 12, č. - (2021), s. 678457
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34489932 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220127145717 $b ABA008
- 999 __
- $a ok $b bmc $g 1751403 $s 1155077
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 12 $c - $d 678457 $e 20210813 $i 1664-3224 $m Frontiers in immunology $n Front Immunol $x MED00181405
- LZP __
- $a Pubmed-20220113